Question reference: S6W-18105
- Asked by: Monica Lennon, MSP for Central Scotland, Scottish Labour
- Date lodged: 19 May 2023
-
Current status: Answered by Jenni Minto on 5 June 2023
Question
To ask the Scottish Government what engagement the Women’s Health Champion has had with (a) NHS Scotland, (b) the Scottish Perinatal Network, (c) patient groups and (d) the diagnostics sector, to ensure the implementation of placental growth factor (PLGF)-based tests for pre-eclampsia, following the recommendation of the Scottish Health Technology Group (SHTG) on 23 March 2023.
Answer
Implementation of placental growth factor (PLGF)-based tests for pre-eclampsia does not feature in the Women’s Health Plan . Professor Anna Glasier OBE, Women’s Health Champion has not, therefore, met with NHS Scotland, the Scottish Perinatal Network, patient groups or the diagnostics sector to discuss this. Professor Glasier set out her initial priorities in our Women’s Health Plan Report on Progress and has met with various stakeholders on a number of other areas of women’s health, mainly related to the priorities of the Women’s Health Plan.
The Scottish Government expects all NHS Boards in Scotland to take note of the Scottish Health Technologies Group (SHTG) recommendations, published on 23 March 2023, and take steps to ensure that any woman who requires access to placental growth factor (PlGF) based tests as part of her maternity care can do so. We wrote to NHS Boards on 23 March, immediately following publication of the SHTG guidance, and will write to NHS Boards again in June, to understand how implementation of PlGF testing is progressing.